Natasha Broyde, MS

Principal Biostatistician
Merck & Co., Inc.

Disclosure(s): Merck Sharp & Dohme LLC,: Current employee, Stocks/Bonds (Public Company)

Poster(s):

• (P-1196) Drug-Drug Interactions (DDIs) With Letermovir (LET) for Cytomegalovirus (CMV) Prophylaxis in Pediatric (Birth to < 18 years of age) Hematopoietic Cell Transplant (HCT) Recipients
  Friday, October 18, 2024

  12:15 PM - 1:30 PM US PT